Walsh Deina H Insider Trades

Insider Trading History

Track insider trading activity for Walsh Deina H. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $133k 8,335 shares
Last Trade
Jan 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$123k 8,335 shares
$14.70
$15.99
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $11.5k 8,335 shares
Last Trade
Jan 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.9k 8,335 shares
$1.55
$1.38
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $433k 27,055 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.61M 27,055 shares
$355.20
$15.99
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $37.3k 27,055 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.2k 27,055 shares
$0.97
$1.38
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $17.3k 12,500 shares
Last Trade
Jan 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.1k 12,500 shares
$3.61
$1.38
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $200k 12,500 shares
Last Trade
Jan 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$353k 12,500 shares
$28.20
$15.99
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $20.7k 15,000 shares
Last Trade
Sep 13, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$42.4k 8,000 shares
$5.30
$1.38
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $240k 15,000 shares
Last Trade
Sep 13, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$408k 8,000 shares
$51.00
$15.99
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $9.66k 7,000 shares
Last Trade
Sep 06, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$40.5k 7,000 shares
$5.79
$1.38
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $112k 7,000 shares
Last Trade
Sep 06, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$210k 7,000 shares
$30.00
$15.99
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $60.5k 43,875 shares
Last Trade
Jan 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$791k 18,875 shares
$41.92
$1.38
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $702k 43,875 shares
Last Trade
Jan 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.53k 18,875 shares
$0.24
$15.99
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $400k 25,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$0 25,000 shares
$0.00
$15.99
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $34.5k 25,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.8M 25,000 shares
$432.43
$1.38
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $54.6k 39,530 shares
Last Trade
Feb 16, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.38
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $632k 39,530 shares
Last Trade
Feb 16, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$15.99
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $178k 11,104 shares
Last Trade
Mar 25, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$15.99
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $15.3k 11,104 shares
Last Trade
Mar 25, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.38
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Financial Officer
Holding Value $7.45M 465,795 shares
Last Trade
Dec 28, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$15.99
Bone Biologics
Bone Biologics BBLG
Chief Financial Officer
Holding Value $643k 465,795 shares
Last Trade
Dec 28, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up